Table 2 Open in new tab Major adverse...

Table 2

Major adverse events at 2-year follow-up from HF diagnosis; comparing HF patients who received exercise-based CR (n = 20 182) to propensity-matched HF patients who received usual care only (n = 20 182)

Major adverse events	% of events	Odds ratio	95% CI	P-value
All-cause mortality	9.3 vs. 15.2	0.58	0.54–0.62	<0.0001
Hospitalization	40.4 vs. 47.8	0.74	0.71–0.77	<0.0001
Incident stroke^a	0.7 vs. 1.2	0.63	0.51–0.79	<0.0001
Incident AF^b	2.2 vs. 4.5	0.47	0.4–0.55	<0.0001

Major adverse events	% of events	Odds ratio	95% CI	P-value
All-cause mortality	9.3 vs. 15.2	0.58	0.54–0.62	<0.0001
Hospitalization	40.4 vs. 47.8	0.74	0.71–0.77	<0.0001
Incident stroke^a	0.7 vs. 1.2	0.63	0.51–0.79	<0.0001
Incident AF^b	2.2 vs. 4.5	0.47	0.4–0.55	<0.0001

AF, atrial fibrillation; CI, confidence interval; CR, cardiac rehabilitation; HF, heart failure.

Subsample of patients with no history of stroke before HF diagnosis (n = 34 756).

Subsample of patients with no history of AF before HF diagnosis (n = 21 006).

This Feature Is Available To Subscribers Only